BioPharmSignal logoBioPharmSignal

Biotech News

NEXGEL Appoints Dave Hazard as Vice President of Sales for BIONX Surgical

NEXGEL (NXGL)NEXGELCompany update

NXGL (NXGL) appears in the live feed after a catalyst-style update. The headline is surfaced in real time so readers can move from signal to source without leaving the product flow.

The source domain is nxgl.com. BioPharmSignal keeps the ticker, timestamp, and source together for faster review before the wider market catches up.

The original release is available below in a new tab so readers can continue into the full source when needed.

Related news

NXGLNEXGEL2026-05-06 13:00 EST

NEXGEL Appoints Brian Kieser and Kevin Harris from New Strategic Partner, Sequence LifeScience™, to Board of Directors

NXGLNEXGEL2026-04-27 13:00 EST

NEXGEL Appoints Ian Blackman as Chief Financial Officer

View all latest news

NEXGEL

NexGel is a hydrogel and wound-care company focused on advanced dressings and delivery materials. Its business is centered on materials science rather than therapeutics or classic biotech.

Recent company news

NXGLNEXGEL2026-06-04 13:00 EST

NEXGEL to Present at Planet MicroCap Conference Las Vegas on June 16th –18th

NXGLNEXGEL2026-05-19 13:00 EST

NEXGEL Reports Positive Data from Randomized Single-Center IRB Study to Evaluate the Effectiveness and Safety of a Hydrogel Laser Treatment Patch in Laser Hair Removal with a 95.6% Reduction in Plume Concentration

NXGLNEXGEL2026-05-13 12:30 EST

NEXGEL Appoints Dave Hazard as Vice President of Sales for BIONX Surgical

NXGLNEXGEL2026-05-12 14:27 EST

NEXGEL To Report First Quarter 2026 Financial Results on May 15th

NXGLNEXGEL2026-05-06 13:00 EST

NEXGEL Appoints Brian Kieser and Kevin Harris from New Strategic Partner, Sequence LifeScience™, to Board of Directors

Stock data

Close
0.34 USD
Market cap
5.31M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States